Valeant Pharmaceuticals International VP of Engineering Salaries in Tampa, FL
The average Valeant Pharmaceuticals International VP of Engineering in Tampa, FL earns an estimated $227,686 annually, which includes an estimated base salary of $184,965 with a $42,721 bonus. Valeant Pharmaceuticals International's VP of Engineering compensation is $23,544 less than the US average for a VP of Engineering. VP of Engineering salaries at Valeant Pharmaceuticals International in Tampa, FL can range from $95,000 - $550,000.
In Tampa, FL, The Engineering Department at Valeant Pharmaceuticals International earns $858 more on average than the Business Development Department.
Last updated 2 years ago.
- $184,965
- avg. base
- $42,721
- avg. bonus
VP of Engineering Salaries at Valeant Pharmaceuticals International
In Tampa, FL, VPs of Engineering earn $30,231 more than Group Engineering Managers.
Compensation at Valeant Pharmaceuticals International by Department
In Tampa, FL, The Engineering Department averages $858 more than the Business Development Department, and $7,535 less than the Operations Department
VP of Engineering Compensation by Gender (All Companies)
The average female VP of Engineering at companies similar size to Valeant Pharmaceuticals International reported making $281,893, while the average male VP of Engineering at similar sized companies reported making $263,157.
VP of Engineering Compensation by Ethnicity (All Companies)
The average Caucasian VP of Engineering at companies similar size to Valeant Pharmaceuticals International reported making $286,544, while the average African American/Black VP of Engineering at similar sized companies reported making $187,625.
How VPs of Engineering at Valeant Pharmaceuticals International Rate Their Compensation
The majority of VPs of Engineering at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of VPs of Engineering at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
